Cite
HARVARD Citation
Schuetze, S. et al. (2016). SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma. Cancer. 122 (6), pp. 868-874. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schuetze, S. et al. (2016). SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma. Cancer. 122 (6), pp. 868-874. [Online].